Stockscreener 앱 받기
5.26
4.78%
0.24
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Ardelyx Announces Three Abstracts Accepted For Poster Presentations At Digestive Disease Week 2025 Conference - marketscreener.com
Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference - The Manila Times
Groundbreaking IBSRELA Pediatric Safety Data Headlines 3 New Studies at Digestive Disease Week 2025 - Stock Titan
(ARDX) Proactive Strategies - news.stocktradersdaily.com
Lobbying Update: $620,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 | ARDX Stock News - GuruFocus
Ardelyx, Inc. Schedules Conference Call to Discuss Q1 2025 Financial Results and Business Update - Nasdaq
Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
April 2025's Top Penny Stocks To Watch - Yahoo Finance
13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey
Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call - The Globe and Mail
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings - The Manila Times
Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event - Investing.com Canada
Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event By Investing.com - Investing.com South Africa
Ontario Teachers' Appoints Terry Hickey as Chief Technology Officer - The Globe and Mail
Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Breakthrough: New Analysis Reveals Better Outcomes for First-in-Class Kidney Drug XPHOZAH - Stock Titan
Ardelyx CEO Michael Raab sells $191k in stock - Investing.com
Ardelyx CEO Michael Raab sells $191k in stock By Investing.com - Investing.com UK
Ardelyx stock hits 52-week low at $4.29 amid challenges By Investing.com - Investing.com South Africa
Ardelyx stock hits 52-week low at $4.29 amid challenges - Investing.com Australia
How To Trade (ARDX) - news.stocktradersdaily.com
Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times
First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan
Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq
Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st
How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx Requests to Dismiss Class Action Filed by Investors - TradingView
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com
ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com
Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia
Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com
Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK
Ardelyx honors inaugural Derek Forfang award winners - Investing.com India
0.24%
36.06%
자본화:
|
볼륨(24시간):